Ronald van Vollenhoven

Amsterdam University Medical Centers — Netherlands

Medicine · Health Sciences

113h-index70.2kcitations980works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Lupus Erythematosus Research(496), Rheumatoid Arthritis Research and Therapies(472), Monoclonal and Polyclonal Antibodies Research(219), Chronic Lymphocytic Leukemia Research(172), Autoimmune and Inflammatory Disorders Research(158)

Publications965 total

Educational Strategies to Prepare Trainees for Clinical Uncertainty
New England Journal of Medicine·2026
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring
Arthritis & Rheumatology·2025· 1 citedOpen Access
Patient–physician discordance in assessing SLE disease activity: longitudinal analysis of disease-related variables and quality of life
Lara D. Veeken·2025
Lupus trials and tribulations: are outcome measures the problem?
EULAR Rheumatology Open·2025Open Access
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality
Annals of the Rheumatic Diseases·2025
Development and validation of a EULAR disease activity score in antiphospholipid syndrome
Annals of the Rheumatic Diseases·2025Open Access
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
New England Journal of Medicine·2025· 9 cited
The EULAR Research Center—5 years young and going strong
EULAR Rheumatology Open·2025Open Access
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective
RMD Open·2025Open Access
15 LLDAS and DORIS remission redefined or refined: the rheumatologist’s perspective
Abstracts·2025Open Access
Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort
Arthritis Research & Therapy·2025Open Access
“Negative” finding supports two‐hit model: comment on the article by Kroese et al
Arthritis & Rheumatology·2025
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus
Advances in Therapy·2025· 2 cited
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritis
PLoS ONE·2025· 1 citedOpen Access
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint
Journal of Translational Autoimmunity·2025Open Access
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort
Arthritis Research & Therapy·2025· 4 citedOpen Access
Association of Soluble Immune Checkpoint Molecules <scp>PD1</scp> and 4‐<scp>1BB</scp> With <scp>CTLA</scp>‐<scp>4Ig</scp> Treatment Response in Early Rheumatoid Arthritis
ACR Open Rheumatology·2025Open Access
Advancing treat-to-target in SLE: a pilot study using a clinical decision support system
Lupus Science & Medicine·2025Open Access
ABS0106 IN VITRO EXPANSION OF ACPA-POSITIVE B CELLS FROM RHEUMATOID ARTHRITIS PATIENTS AND THE EFFECTS OF TARGETING NF-?B ON DIFFERENTIATION AND SURVIVAL OF (AUTOREACTIVE) B LINEAGE CELLS
Annals of the Rheumatic Diseases·2025Open Access
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial
RMD Open·2025· 1 citedOpen Access
page 1 of 49Next →

Frequent Co-authors

Paul Emery(16), Caroline Gordon(14), Josef S Smolen(14), Martin Aringer(12), Michelle Petri(11), David Isenberg(11), Ricard Cervera(11), Désirée van der Heijde(10), Ian N Bruce(10), Matthias Schneider(10), Karel Pavelká(9), Gerd R Burmester(9), George Βertsias(9), Robert Landewé(8), Maxime Dougados(8), Ann E. Clarke(8), David Jayne(8), Sang‐Cheol Bae(7), Cynthia Aranow(7), Asad Zoma(7)